Manuscripts
Showing 1530 manuscripts.
Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.
Citation
Ann Melvin, Lisa Aaron, Grace Montepiedra, William Meyer, Hans Spiegel, William Borkowsky, Mark Abzug, Brookie Best, Marilyn Crain, Peggy Borum, Bobbie Graham, Patty Anthony, Katie Shin, George Siberry for the P1063 study team. Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.. Pediaric Infectious Disease Journal. 2017. 36: 53-60. PMID: 27749649Year
2017
Journal
Pediaric Infectious Disease Journal
Study
P1063
Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa
Citation
MJ Levin, JC Lindsey, SS Kaplan, W Schimana, J Lawrence, M McNeal, M Bwakura-Dangarembizi, A Ogwu, E Mpabalwani, B Heckman, P Sato, GK Siberry, M Nelson, D Hille, GA Weinberg, A Weinberg for the IMPAACT P1072 team. Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa. AIDS. 2017. 2: 49-59. PMID: 27662551Year
2017
Journal
AIDS
Study
P1072
Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041
Citation
Bret Zeldow, Soyeon Kim, George McSherry, Mark Cotton, Patrick Jean-Philippe, Avy Violari, Raziya Bobat, Sharon Nachman, Lynne Mofenson, Shabir Madhi, Charles Mitchell. Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041. International Journal of Tuberculosis and Lung Disease. 2017. 21: 38-45. PMID: 28157463Year
2017
Journal
International Journal of Tuberculosis and Lung Disease
Study
P1041
Pharmacokinetics of Unboosted Atazanavir in Treatment-Experienced HIV-infected Children, Adolescents and Young Adults
Citation
Tim Cressey, Rohan Hazra, Andrew Wiznia, Marc Foca, Patrick Jean-Philipe, Bobbie Graham, Jennifer King, Paula Britto, Vincent Carey, Edward Acosta, Ram Yogev for the IMPAACT P1058A team. Pharmacokinetics of Unboosted Atazanavir in Treatment-Experienced HIV-infected Children, Adolescents and Young Adults. Pediatric Infectious Disease Journal. 2016. 35: 1333-1335. PMID: 27583590Year
2016
Journal
Pediatric Infectious Disease Journal
Study
P1058A
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor-Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
Citation
Charlotte Hobbs, Erin Gabriel , Portia Kamthunzi, Gerald Tegha, Elizabeth Wills Petzold, Linda Barlow-Mosha, Ben Chi, Yonghua Li, Tiina Ilmet, Brian Kirmse, Jillian Neal, Sunil Parikh, Nagamah Deygoo, Patrick Jean Philippe, Lynne Mofenson, Roy Prescott, Philippa Musoke, Paul Palumbo, Patrick Duffy, William Borkowsky for the P1068s team. Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor-Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. PLoS One. 2016. 11: e0165140. PMID: 27936233Year
2016
Journal
PLoS One
Study
P1068S
Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized study
Citation
Linda Barlow-Mosha, Konstantia Angelidou, Jane Lindsey, Moherndran Archary, Mark Cotton, Sylvia Dittmer, Lee Fairlie, Enid Kabugho, Portia Kamthunzi, Arti Kinikar, Tapiwa Mbengeranwa, Levina Msuya, Pauline Sambo, Kunjal Patel, Emily Barr, Patrick Jean-Phillipe, Avy Violari, Lynne Mofenson, Paul Palumbo, Benjamin H Chi. Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized study. Clinical Infectious Diseases. 2016. 63: 1113-21. PMID: 27439527Year
2016
Journal
Clinical Infectious Diseases
Study
P1060
Rilpivirine Pharmacokinetics With and Without Darunavir/Ritonavir Once Daily in Adolescents and Young Adults
Citation
Marc Foca, Ram Yogev, Andrew Wiznia, Rohan Hazra, Patrick Jean-Philippe, Bobbie Graham, Paula Britto, Vincent J Carey, Jennifer King, Edward P Acosta, Tim R Cressey. Rilpivirine Pharmacokinetics With and Without Darunavir/Ritonavir Once Daily in Adolescents and Young Adults. Pediatric Infectious Disease Journal. 2016. 35: e271-4. PMID: 27187753Year
2016
Journal
Pediatric Infectious Disease Journal
Complications and route of delivery in a large cohort study of HIV-1-infected women - IMPAACT P1025
Citation
Elizabeth G. Livingston , Yanling Huo , Kunjal Patel , Ruth E. Tuomala , Gwendolyn B. Scott , Alice Stek and the P1025 Team. Complications and route of delivery in a large cohort study of HIV-1-infected women - IMPAACT P1025. Journal of Acquired Immune Deficiency Syndromes. 2016. 73: 74-82. PMID: 27082506Year
2016
Journal
Journal of Acquired Immune Deficiency Syndromes
Cost-effectiveness of Pre-Exposure HIV Prophylaxis During Pregnancy and Breast feeding in Sub-Saharan Africa
Citation
Joan Price, Stephanie Wheeler, Lynda Stranix-Chibanda, Sybil Hosek, D. Heather Watts, George Siberry, Jeffrey Stringer, Benjamin Chi. Cost-effectiveness of Pre-Exposure HIV Prophylaxis During Pregnancy and Breast feeding in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes. 2016. 1: s145-53. PMID: 27355502Year
2016
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2009